Integral Health Asset Management LLC Takes Position in Humana Inc. (NYSE:HUM)

Integral Health Asset Management LLC purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 40,000 shares of the insurance provider's stock, valued at approximately $10,148,000.

Other hedge funds also recently added to or reduced their stakes in the company. Transcend Capital Advisors LLC lifted its stake in Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC raised its position in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after purchasing an additional 26,856 shares during the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after purchasing an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. grew its position in Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC acquired a new position in Humana in the fourth quarter valued at $244,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HUM shares. JPMorgan Chase & Co. lowered their price target on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Robert W. Baird upped their price target on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. StockNews.com raised Humana from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Raymond James raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Finally, Morgan Stanley reduced their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $286.81.

Humana Price Performance

Shares of Humana stock traded down $4.21 on Thursday, hitting $226.26. The company's stock had a trading volume of 4,228,584 shares, compared to its average volume of 1,764,056. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a fifty day moving average price of $263.70 and a 200-day moving average price of $269.85. Humana Inc. has a 52-week low of $212.58 and a 52-week high of $406.46. The company has a market capitalization of $27.31 billion, a P/E ratio of 22.74, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The company's revenue was up 8.4% on a year-over-year basis. During the same period last year, the company posted $7.23 EPS. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.56%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.